Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
Seon Mee Kang, Jeong Hyun Park
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14, pp. 117955142110516-117955142110516
Open Access | Times Cited: 20

Showing 20 citing articles:

C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease—Advancing toward Precision Medicine
Emanuel Amezcua-Castillo, Héctor González‐Pacheco, Arturo Sáenz-San Martín, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2444-2444
Open Access | Times Cited: 47
The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations
Nicholas Aderinto, Gbolahan Olatunji, Muili Abdulbasit, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35557-e35557
Open Access | Times Cited: 25
To do one and to get more: Part I. Diabetes and bone
Wen-Ling Lee, Peng‐Hui Wang, Szu‐Ting Yang, et al.
Journal of the Chinese Medical Association (2022) Vol. 85, Iss. 10, pp. 965-971
Open Access | Times Cited: 21
VILDAGLIPTIN IMPROVES DETRUSOR CONTRACTILITY IN A MOUSE MODEL OF CYCLOPHOSPHAMIDE-INDUCED OVERACTIVE BLADDER
Seçkin Engin, Elif Nur Barut, M Karaca, et al.
Ankara Universitesi Eczacilik Fakultesi Dergisi (2025) Vol. 49, Iss. 1, pp. 5-5
Open Access
Synthetic Approaches to Novel DPP-IV Inhibitors—A Literature Review
Valentin Petrov, Teodora Aleksandrova, Aleksandar Pashev
Molecules (2025) Vol. 30, Iss. 5, pp. 1043-1043
Open Access
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes
Daniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
The American Journal of Cardiology (2024) Vol. 221, pp. 52-63
Closed Access | Times Cited: 3
The impact of DPP-4 inhibitors on cardiovascular disease treatment: a comprehensive review of current therapeutic strategies and future directions
Toka Elemary, Mina Nicola, Mohamed E. A. Abdelrahim, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
Richeek Pradhan, Oriana Hoi Yun Yu, Robert W. Platt, et al.
BMJ Open Diabetes Research & Care (2023) Vol. 11, Iss. 6, pp. e003550-e003550
Open Access | Times Cited: 9
Effects of dipeptidyl peptidase 4 inhibition on the endothelial control of the vascular tone
João Carlos Ribeiro-Silva, Vinícius Bermond Marques, Leonardo dos Santos
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C972-C980
Closed Access | Times Cited: 8
Bioactivity Guided Study for the Isolation and Identification of Antidiabetic Compounds from Edible Seaweed—Ulva reticulata
Pullikaparambil Sasidharan Unnikrishnan, Andhere Animish, Gunabalan Madhumitha, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8827-8827
Open Access | Times Cited: 11
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
Dana Shalmon, Efrat Bar‐Ilan, A. Peled, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv26663-adv26663
Open Access | Times Cited: 1
Neurological Sequelae of Post-COVID-19 Fatigue: A Narrative Review of Dipeptidyl Peptidase IV-Mediated Cerebrovascular Complications
Che Mohd Nasril Che Mohd Nassir, Muhammad Danial Che Ramli, Usman Jaffer, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 13565-13582
Open Access | Times Cited: 1
Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes
Kozo Okada, Shinnosuke Kikuchi, Shotaro Kuji, et al.
Atherosclerosis (2022) Vol. 360, pp. 1-7
Open Access | Times Cited: 6
Clinical and Pharmacotherapeutic Profile of Patients with Type 2 Diabetes Mellitus Admitted to a Hospital Emergency Department
António Cabral Lopes, Olga Lourenço, Fátima Roque, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 256-256
Open Access | Times Cited: 1
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis
Shangyu Chai, Ruya Zhang, Richard D. Carr, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
Synergistic effects of GABA and hypoglycemic drugs
I. N. Tyurenkov, T. I. Faibisovich, Д. А. Бакулин
Problems of Endocrinology (2023) Vol. 69, Iss. 4, pp. 61-69
Open Access | Times Cited: 1
Proteína C reactiva, aspectos cardiovasculares de una proteína de fase aguda: una actualización para el médico
Arturo Sáenz-San Martín, Pablo Méndez-Ocampo, Iván Gutiérrez-Moctezuma, et al.
Archivos de cardiología de México (2024) Vol. 94, Iss. 2
Open Access
In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors
Halide Edip Temel, Mehlika Dilek Altıntop, Belgin Sever, et al.
Turkish Journal of Biochemistry (2022) Vol. 48, Iss. 1, pp. 104-109
Open Access | Times Cited: 1
İleri Evre Kronik Böbrek Hastalarında, Dipeptidl Peptidaz-4 İnhibitörlerinin Böbrek Fonksiyonu Üzerindeki Etkisi
Mahmud İslam, Ahmed Cihad Genç
JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH (2023) Vol. 7, Iss. 3, pp. 166-173
Open Access
National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus
М. В. Шестакова, Gulnar Vagapova, Olga Konstantinovna Vikulova, et al.
Diabetes Mellitus (2023) Vol. 26, Iss. 6, pp. 619-625
Open Access
Page 1

Scroll to top